Figure 2

Changes on the seven-category ordinal scale from antiviral initiation to the end of follow-up in (A) Nirmatrelvir-ritonavir (NR) group and (B) Azvudine (FNC) group.

Changes on the seven-category ordinal scale from antiviral initiation to the end of follow-up in (A) Nirmatrelvir-ritonavir (NR) group and (B) Azvudine (FNC) group.